Medicare Enrolled

Dr. Christine Leehealey, MD

Rheumatology · Irvine, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
4950 BARRANCA PKWY, Irvine, CA 92604
9496543763
In practice since 2006 (19 years)
NPI: 1316055809 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Leehealey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Leehealey? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Leehealey

Dr. Christine Leehealey is a rheumatology specialist in Irvine, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Leehealey performed 522 Medicare services across 320 unique beneficiaries.

Between the years covered by Open Payments, Dr. Leehealey received a total of $17,202 from 42 pharmaceutical and/or device companies across 945 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Leehealey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 522 Medicare services $17,202 industry payments

Medicare Practice Summary

Medicare Utilization ↗
522
Medicare services
Bottom 38% in CA for rheumatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
320
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~27 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 437 $104 $240
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
 69 $135 $360
Intravenous drug injection
A procedure involving the administration of a medication or substance directly into a vein.
 16 $35 $135
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$17,202
Total received (2018-2024)
Avg $2,457/year across 7 years
Top 19% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
945
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,177 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$25 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,030
2023
$2,940
2022
$2,814
2021
$2,380
2020
$1,055
2019
$2,554
2018
$2,429

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$709
Amgen Inc.
$528
Janssen Biotech, Inc.
$369
Boehringer Ingelheim Pharmaceuticals, Inc.
$294
Lilly USA, LLC
$246
Novartis Pharmaceuticals Corporation
$199
PFIZER INC.
$145
UCB, Inc.
$140
Fresenius Kabi USA, LLC
$78
Radius Health, Inc.
$58
E.R. Squibb & Sons, L.L.C.
$54
Mallinckrodt Hospital Products Inc.
$51
Kiniksa Pharmaceuticals International, plc
$50
AstraZeneca Pharmaceuticals LP
$36
ANI Pharmaceuticals, Inc.
$28
SCILEX PHARMACEUTICALS INC.
$23
GlaxoSmithKline, LLC.
$21
Top 3 companies account for 53.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$3,010
ABBVIE INC.
$1,872
Lilly USA, LLC
$1,809
Novartis Pharmaceuticals Corporation
$1,222
Janssen Biotech, Inc.
$1,174
PFIZER INC.
$1,163
Boehringer Ingelheim Pharmaceuticals, Inc.
$806
AbbVie, Inc.
$781
GlaxoSmithKline, LLC.
$714
Horizon Therapeutics plc
$626
AbbVie Inc.
$528
Aurinia Pharma U.S., Inc.
$452
Celgene Corporation
$439
UCB, Inc.
$360
AstraZeneca Pharmaceuticals LP
$333
Radius Health, Inc.
$244
Fresenius Kabi USA, LLC
$173
Hikma Pharmaceuticals USA
$171
E.R. Squibb & Sons, L.L.C.
$161
Mallinckrodt Hospital Products Inc.
$144
Horizon Pharma plc
$133
Genentech USA, Inc.
$132
La Jolla Pharmaceutical Company
$125
GENZYME CORPORATION
$112
West-Ward Pharmaceuticals
$83
Kiniksa Pharmaceuticals International, plc
$50
Mallinckrodt LLC
$47
Antares Pharma, Inc.
$38
SANOFI-AVENTIS U.S. LLC
$31
Merck Sharp & Dohme Corporation
$31
MEDEXUS PHARMA, INC.
$28
ANI Pharmaceuticals, Inc.
$28
Sanofi Pasteur Inc.
$25
SCILEX PHARMACEUTICALS INC.
$23
Metacel Pharmaceuticals LLC
$23
Alvogen Inc
$22
Mallinckrodt Enterprises LLC
$20
Alexion Pharmaceuticals, Inc.
$16
Daiichi Sankyo Inc.
$16
Takeda Pharmaceuticals U.S.A., Inc.
$14
ASSERTIO THERAPEUTICS, Inc.
$12
MEDAC PHARMA, INC.
$11
Top 3 companies account for 38.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Arcalyst · BELSOMRA · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · EVENITY · EVUSHELD · Enbrel · FORTEO · GIAPREZA · Gralise · HUMIRA · Humira · IDACIO · INFLECTRA · KEVZARA · KRYSTEXXA · LUPKYNIS · LYRICA · Mitigare · Movantik · NO PRODUCT DISCUSSED · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · ORENCIA · Otezla · Otrexup · Ozobax · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · Uloric · XELJANZ · XYOSTED · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Irvine?
Compare rheumatologists in the Irvine area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
92
Per 100K population
2.9
County median income
$113,702
Nearest hospital
HOAG ORTHOPEDIC INSTITUTE
3.6 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Leehealey is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 19% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Leehealey experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Leehealey performed 437 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Leehealey receive payments from pharmaceutical companies?
Yes. Dr. Leehealey received a total of $17,202 from 42 companies across 945 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Leehealey's costs compare to other rheumatologists in Irvine?
Dr. Leehealey's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Leehealey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Rheumatologists in Irvine
Browse rheumatologists in Irvine ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in CA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in CA
Which CA rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →